| 20/01 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |  |
| 20/01 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 10/01 | Tela Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | |
| 09/01 | Tela Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 09/01 | TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The .. | |
| 09/01 | TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The .. | |
| 09/01 | TELA Bio Announces U.S. Commercial Launch of NIVIS Fibrillar Collagen Pack | |
| 2022 | TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference | |
| 2022 | TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference | |
| 2022 | Certain Warrants of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14-NOV.. | |
| 2022 | Certain Stock Options of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14.. | |
| 2022 | Certain Common Stock of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14-.. | |
| 2022 | TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | |
| 2022 | Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, .. | |
| 2022 | TELA Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep.. | |
| 2022 | Earnings Flash (TELA) TELA BIO Posts Q3 Revenue $11.2M | |
| 2022 | Earnings Flash (TELA) TELA BIO Posts Q3 Revenue $11.2M | |
| 2022 | TELA Bio Reports Third Quarter 2022 Financial Results | |
| 2022 | TELA Bio Reports Third Quarter 2022 Financial Results | |
| 2022 | TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2022 | |
| 2022 | TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services.. | |
| 2022 | TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services.. | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio to Announce Third Quarter 2022 Financial Results | |
| 2022 | Tela Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 2022 | TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits o.. | |
| 2022 | TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits o.. | |
| 2022 | TELA Bio, Inc. Announces Publication of 24-Month Bravo Study Results Demonstrating Bene.. | |
| 2022 | TELA Bio, Inc.(NasdaqGM:TELA) dropped from S&P Global BMI Index | |
| 2022 | TELA Bio to Participate in Upcoming Investor Conferences | |
| 2022 | TELA Bio to Participate in Upcoming Investor Conferences | |
| 2022 | TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase | |
| 2022 | TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase | |
| 2022 | TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Unde.. | |
| 2022 | TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Unde.. | |
| 2022 | Tela Bio, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhi.. | |
| 2022 | TELA Bio Prices Common Stock Offering at $8 Apiece | |
| 2022 | TELA Bio Announces Pricing of Public Offering of Common Stock | |
| 2022 | TELA Bio Announces Pricing of Public Offering of Common Stock | |
| 2022 | TELA Bio's Q2 Loss Widens, Revenue Rises; Adjusts FY 2022 Revenue Estimate | |
| 2022 | TELA Bio Announces Proposed Public Offering of Common Stock | |
| 2022 | Tela Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | |
| 2022 | TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | |
| 2022 | Tela Bio : Reports Second Quarter 2022 Financial Results - Form 8-K | |
| 2022 | TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun.. | |
| 2022 | Earnings Flash (TELA) TELA BIO Posts Q2 Revenue $10.4M, vs. Street Est of $10.1M | |
| 2022 | TELA Bio Reports Second Quarter 2022 Financial Results | |
| 2022 | TELA Bio Reports Second Quarter 2022 Financial Results | |
| 2022 | TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2022 | |
| 2022 | TELA Bio to Participate in Upcoming Investor Conferences | |
| 2022 | TELA Bio to Participate in Upcoming Investor Conferences | |
| 2022 | TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Rei.. | |
| 2022 | Tela Bio, Inc. Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTe.. | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio to Announce Second Quarter 2022 Financial Results | |
| 2022 | TELA Bio Secures Group Purchasing Agreement With Premier for Bioabsorbable Products | |
| 2022 | TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc. | |
| 2022 | TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc. | |
| 2022 | TELA Bio, Inc. Wins Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc | |
| 2022 | Top Premarket Gainers | |
| 2022 | Tela Bio, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 2022 | TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference | |
| 2022 | TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference | |
| 2022 | Tela Bio : Material Definitive Agreement - Form 8-K | |
| 2022 | Tela Bio, Inc. : Entry into a Material Definitive Agreement, Termination of a Material Def.. | |
| 2022 | TELA Bio Enters Into New $50 Million Credit Facility With MidCap Financial | |
| 2022 | TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial | |
| 2022 | TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial | |
| 2022 | TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial | |
| 2022 | TELA Bio to Participate in Upcoming Jefferies Healthcare Conference | |
| 2022 | TELA Bio, Inc. Provides Revenue Guidance for the Fiscal Year 2022 | |
| 2022 | TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | |
| 2022 | Spectrum Pharmaceuticals Names Nora Brennan CFO | |
| 2022 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $8.2M, vs. Street Est of $7.95M | |
| 2022 | TELA Bio's Q1 Loss Widens, Revenue Rises; Maintains 2022 Sales Guidance | |
| 2022 | Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, .. | |
| 2022 | TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | TELA Bio Reports First Quarter 2022 Financial Results | |
| 2022 | TELA Bio Reports First Quarter 2022 Financial Results | |
| 2022 | TELA Bio, Inc. Announces Revenue Guidance for the Full Year 2022 | |
| 2022 | TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conf.. | |
| 2022 | TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conf.. | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 2022 | TELA Bio to Announce First Quarter 2022 Financial Results | |
| 2022 | TELA Bio Appoints D. Taylor Ocasio as General Counsel | |
| 2022 | TELA Bio, Inc. Appoints Taylor Ocasio as General Counsel | |
| 2022 | TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Confer.. | |
| 2022 | TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Confer.. | |
| 2022 | TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS.. | |
| 2022 | Tela Bio Posts Wider Q4 Net Loss, Higher Revenue; Warns of Potential Pandemic-Related I.. | |
| 2022 | Tela Bio : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K | |
| 2022 | Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, .. | |
| 2022 | TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
